Yelee Kwon

Yelee Kwon

Auto-generated profile, based on publicly available information

Yelee Kwon

Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2025 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
YKYelee Kwon
Yelee Kwon
JYJae Kwang Yun
Jae Kwang Yun
YJYun-Ho Jeon
Yun-Ho Jeon
YKYong-Hee Kim
Yong-Hee Kim

22 November 2021 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
YKYelee Kwon
Yelee Kwon
SPSung Jun Park
Sung Jun Park
HKHo Jin Kim
Ho Jin Kim
JKJoon Bum Kim
Joon Bum Kim
SJSung-Ho Jung
Sung-Ho Jung
JLJae Won Lee
Jae Won Lee
: OBJECTIVES: Right mini-thoracotomy approach may enhance the visualization of mitral valve (MV) visualization during redo MV surgery, thereby minimizing the risk of reoperative median sternotomy. We described the clinical outcomes of redo MV surgery by mini-thoracotomy and full-sternotomy approach. METHODS: Of 730 consecutive adult patients who underwent redo MV surgery between 2002 and 2018 at our institution, we identified 380 patients (age: 56.0 [14.8] years) after excluding those who underwent concomitant aortic valve or coronary artery surgeries. RESULTS: The clinical outcomes in patients who underwent mini-thoracotomy (MINI group; n = 168) and full-sternotomy (STERN group; n = 218) were described. The early and overall mortality in the MINI group was 4.3% (7/162) and 17.3% (28/162), with the rates of early major complications as follows: low cardiac output syndrome, 5.6% (9/162); early stroke, 6.8% (11/162); new-onset dialysis, 6.2% (10/162); prolonged ventilation, 15.4% (25/162); and postoperative bleeding requiring exploration, 7.4% (12/162). In the STERN group, the early mortality was 11.0% (24/218), whereas the risk of low cardiac output syndrome, early stroke, new-onset dialysis, prolonged ventilation, and postoperative bleeding was 12.4% (27/218), 14.2% (31/218), 17.0% (37/218), 33.0% (72/218), and 10.1% (22/218), respectively. The duration of intensive care unit and hospital stay was 2.0 [range 1.0, 3.0] and 8.0 [6.0, 13.0], respectively, in the MINI group and 3.0 [2.0, 7.0] and 14.0 [8.0, 29.0], respectively, in the STERN group. CONCLUSIONS: Mini-thoracotomy may be a viable alternative to conventional sternotomy for redo MV surgery.

4 September 2020 in The Korean Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Open access
PDF file
YKYelee Kwon
Yelee Kwon
YCYoungjong Cho
Youngjong Cho
PKPil Je Kang
Pil Je Kang
WCWon Chul Cho
Won Chul Cho
M.M.D.
M.D.
PHPh.D.
Ph.D.
Yelee Kwon, M.D., Young Jong Cho, M.D., Pil Je Kang, M.D., Won Chul Cho, M.D., Ph.D.. Korean Journal of Thoracic and Cardiovascular Surgery 2020;53:297-300. https://doi.org/10.5090/kjtcs.20.008

15 October 2025 in Cancer Research and Treatment
Verified
Journal Article
Open access
PDF file
YKYelee Kwon
Yelee Kwon
JYJae Kwang Yun
Jae Kwang Yun
GLGeun Dong Lee
Geun Dong Lee
SCSe Hoon Choi
Se Hoon Choi
YKYong-Hee Kim
Yong-Hee Kim
HKHyeong Ryul Kim
Hyeong Ryul Kim
Purpose This study aimed to evaluate the clinical impact of main tumor resection on long-term survival compared with pleural biopsy alone in patients with lung adenocarcinoma who were intraoperatively diagnosed with pleural metastasis.Materials and Methods A total of 176 patients with adenocarcinoma who had unexpected pleural metastasis detected during surgery from 2002 to 2021 were retrospectively analyzed. Each surgeon decided whether to perform main tumor resection or pleural biopsy alone.Results The patients were grouped based on the surgical approaches: main tumor resection (resection group; n=83) and pleural biopsy only (O&C group; n=93). The resection group had better overall survival (OS; 10-year survival, 27.9% vs. 9.4%; median survival, 68.3 vs. 36.6 months; p < 0.01) and locoregional progression-free survival (10-year survival, 12.5% vs. 7.1%; median survival, 19.6 vs. 10.6 months; p < 0.01) than the O&C group. Similar results were found for OS in patients who received tyrosine kinase inhibitors (TKIs) as first-line therapy (10-year survival, 49.2% vs. 15.0%; median survival, 72.2 vs. 45.4 months; p=0.03), patients who did not undergo TKIs treatment (10-year survival, 29.4% vs. 9.2%; median survival, 82.4 vs. 23.8 months; p < 0.01), and patients with positive target gene mutation (10-year survival, 31.7% vs. 10.1%; median survival, 72.2 vs. 33.7 months; p < 0.01). In multivariate analysis, pleural biopsy only (hazard ratio, 1.73; p=0.04) was a significant predictor of OS.Conclusion Main tumor resection can improve survival in patients with lung adenocarcinoma who had unexpected pleural metastasis during operation.

8 August 2024 in Journal of Chest Surgery
Verified
Journal Article
Open access
PDF file
HPHyo Kyen Park
Hyo Kyen Park
YKYelee Kwon
Yelee Kwon
GLGeun Dong Lee
Geun Dong Lee
SCSehoon Choi
Sehoon Choi
HKHyeong Ryul Kim
Hyeong Ryul Kim
JYJae Kwang Yun
Jae Kwang Yun
Hyo Kyen Park, M.D., Yelee Kwon, M.D., Geun Dong Lee, M.D., Ph.D., Sehoon Choi, M.D., Ph.D., Hyeong Ryul Kim, M.D., Ph.D., Yong-Hee Kim, M.D., Ph.D., Dong Kwan Kim, M.D., Ph.D., Seung-Il Park, M.D., Ph.D., Jae Kwang Yun, M.D., Ph.D.. J Chest Surg 2024;57:467-76. https://doi.org/10.5090/jcs.24.022

22 April 2025 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
YKYelee Kwon
Yelee Kwon
JYJae Kwang Yun
Jae Kwang Yun
HKHyeong Ryul Kim
Hyeong Ryul Kim
YKYong-Hee Kim
Yong-Hee Kim